Opia Limited has been acquired by Village Roadshow Limited
The shareholders of Opia Limited have sold the company to Village Roadshow Limited for US$35 million.
Opia Limited is a sales promotion consultancy focusing on creating compelling end user and reseller risk managed promotional campaigns which differentiate customers' products from competitors, generate genuine added value and most importantly drive sell out and increase margins.
Village Roadshow Limited is an Australian media company with interests in cinema, theme parks, film production and distribution. Founded in 1954 in Melbourne, Australia, with a drive-in cinema, Village Roadshow has been listed on the Australian Securities Exchange (ASX) since 1988. In film, Village Roadshow is a major movie producer and film and DVD distributor as well as operator of cinema exhibition circuits. In movie production, the company is one of the most successful independent producers in Hollywood.
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more